Brief: Allergy Therapeutics Announces Grass Mata Mpl Phase III Data Published In Allergy
17/02/2025 07:27
Feb 17 (Reuters) - Allergy Therapeutics PLC AGY.L :
* GRASS MATA MPL PHASE III DATA PUBLISHED IN ALLERGY
* PHASE III TRIAL SHOWS 20.3% REDUCTION IN CSMS COMPARED TO
PLACEBO
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update